Hypersensitivity to IV Ustekinumab but Tolerance to Subcutaneous Ustekinumab in a Patient With Crohn's Disease

Ustekinumab is a monoclonal antibody against the p40 subunit of interleukin (IL)-12 and IL-23 and is US Food and Drug Administration (FDA)-approved for plaque psoriasis, moderately to severely active Crohn's disease, and ulcerative colitis. We describe a case of an immediate hypersensitivity re...

Descripción completa

Detalles Bibliográficos
Autores principales: Krugliak Cleveland, Noa, Masching, Alexandra, Rubin, David T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449253/
https://www.ncbi.nlm.nih.gov/pubmed/32904020
http://dx.doi.org/10.14309/crj.0000000000000449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449253/
https://www.ncbi.nlm.nih.gov/pubmed/32904020
http://dx.doi.org/10.14309/crj.0000000000000449

Ejemplares similares